Key takeaways
Humira (adalimumab) and Tazarotene (Tazorac) are both prescription medications, but they are used for different conditions and work in different ways. Humira is an injectable biologic Disease Modifying Anti-Rheumatic Drug (DMARD) used to treat various autoimmune conditions like rheumatoid arthritis, Crohn's disease, and plaque psoriasis. It works by blocking a protein called tumor necrosis factor (TNF) to reduce inflammation. On the other hand, Tazarotene is a topical retinoid used mainly for treating acne and plaque psoriasis. It helps skin cells renew faster, improving skin appearance and texture. Humira is administered subcutaneously every other week, while Tazarotene is applied daily to the skin. Humira can be used in children as young as 2 years old for some conditions, whereas Tazarotene is approved for children as young as 9 years and older. Humira has serious risks like infections and cancer, while Tazarotene mainly causes skin irritation and increased sun sensitivity. Additionally, Tazarotene is not safe during pregnancy, whereas Humira has no such restriction.
